Categories: AppsBrainNews

Amicus Brain Unveils Amicus INTERACT, an AI App Tackling Dementia-Related Loneliness

Empowering meaningful conversations and preserving independence for people living with dementia 

CHAPPAQUA, N.Y., Dec. 18, 2025 /PRNewswire/ — Amicus Brain Innovations today announced the launch of Amicus INTERACT, a first-of-its-kind AI-powered application designed to provide real-time guidance that enables meaningful conversations and helps reduce the social isolation often caused by memory loss and communication challenges. Amicus INTERACT—short for Insightful Navigation to Enrich Relationships, Amplify Connections, and Togetherness—is now available on the Apple App Store and Google Play. 

As dementia progresses, communication can become increasingly difficult, leading to loneliness for both individuals and their loved ones. Amicus INTERACT provides a single, easy-to-use platform to start new conversations or respond to messages across text, WhatsApp, email and other communication channels. With AI support that adapts to the evolving needs of older adults, the app ensures that every message reflects the user’s own voice and words.

“We created Amicus INTERACT to give a voice to those who need it most,” said Dr. Dorai, AI researcher and CEO of Amicus Brain Innovations. “By harnessing AI responsibly, we enable people with dementia to express themselves more clearly and engage more fully in their relationships, thus restoring independence in communications.”

Research shows that socially isolated older adults are 28% more likely to develop dementia, and loneliness itself increases dementia risk by 31%. In fact, late-life social isolation is estimated to contribute to around 5% of all dementia cases worldwide. By restoring confidence and clarity in communication, Amicus INTERACT helps preserve independence, strengthen social connections, and combat the loneliness that can accelerate cognitive decline. 

“True innovation in the longevity economy isn’t just about building smarter hardware; it’s about designing solutions that restore dignity and choice. What stands out about Amicus Brain is how they are leveraging AI to tackle one of the most pervasive challenges of aging—social isolation. By using technology to bridge the communication gap, innovative apps like Amicus INTERACT can help empower older adults to remain the authors of their own stories and maintain the deep, meaningful connections that are vital for a joyful life,” said Andy Miller, Senior Vice President, AgeTech Collaborative.

The app has been enthusiastically embraced by people with dementia, their care partners, and professionals who support them. One early user shared: “Love it, love it, love it! Using it early on… I’ll be well prepared.” Another noted: “The app adapts to individuals as their dementia progresses, which has the potential to be a game-changer.”

Amicus INTERACT is now available for download with a free trial. 

About Amicus Brain Innovations

Amicus Brain Innovations delivers AI-powered solutions designed to support individuals living with dementia and those who care for them. By applying the principles of Responsible AI, Amicus Brain brings practical tools to the marketplace that promote independence, dignity, and improved quality of life for those affected by cognitive decline.

Media Contact:
Dr. Chitra Dorai
CEO, Amicus Brain Innovations
Email: 406644@email4pr.com
Phone: +1 914 673 2894
www.amicusbrain.com 

View original content to download multimedia:https://www.prnewswire.com/news-releases/amicus-brain-unveils-amicus-interact-an-ai-app-tackling-dementia-related-loneliness-302645540.html

SOURCE Amicus Brain Innovations

Staff

Recent Posts

Olympian Gabby Thomas Draws Crowd at Wellness Event with BetterWay(TM) Blood Testing at H-E-B SoCo

Guests had an opportunity to meet Gabby Thomas, win health-focused prizes, and learn simple ways…

5 hours ago

UOG (United One Group) Wins Three Prestigious Industry Awards at CES 2026

CES Official Spokesperson Highlights UOG Featured ProductsIntroducing the World's First Black Diamond Carbon & Nano…

14 hours ago

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

17 hours ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

17 hours ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

17 hours ago